Published in Nature on October 29, 1985
Yeast MIG1 repressor is related to the mammalian early growth response and Wilms' tumour finger proteins. EMBO J (1990) 5.10
Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol (1992) 3.11
Insulin-like growth factors and cancer. Br J Cancer (1992) 2.31
novH: differential expression in developing kidney and Wilm's tumors. Am J Pathol (1998) 1.90
Sequences of liver cDNAs encoding two different mouse insulin-like growth factor I precursors. Nucleic Acids Res (1986) 1.79
Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis. Am J Pathol (2001) 1.49
Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. Proc Natl Acad Sci U S A (1989) 1.48
Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor. J Clin Invest (1990) 1.44
Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J Clin Invest (1989) 1.41
Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc Natl Acad Sci U S A (1995) 1.33
The role of IGF-1R in pediatric malignancies. Oncologist (2009) 1.27
An extensive genetic program occurring during postnatal growth in multiple tissues. Endocrinology (2008) 1.24
Isolation and characterization of a cDNA encoding the low molecular weight insulin-like growth factor binding protein (IBP-1). EMBO J (1988) 1.15
Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J Clin Invest (1991) 1.15
Insulinlike growth factor II expression and oval cell proliferation associated with hepatocarcinogenesis in woodchuck hepatitis virus carriers. J Virol (1988) 1.14
Parental allele specific methylation of the human insulin-like growth factor II gene and Beckwith-Wiedemann syndrome. J Med Genet (1993) 1.11
Insulin-like growth factor 2 and short-range stimulatory loops in control of human placental growth. EMBO J (1989) 1.08
Expression of insulin-like growth factor-I and -II genes in human smooth muscle tumours. EMBO J (1988) 1.08
Evasion mechanisms to Igf1r inhibition in rhabdomyosarcoma. Mol Cancer Ther (2011) 1.07
Tissue-specific expression of insulin-like growth factor II mRNAs with distinct 5' untranslated regions. Proc Natl Acad Sci U S A (1987) 1.05
Antibody to type I insulinlike growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic mice. Am J Pathol (1989) 1.04
Hepatitis B virus infection and primary hepatocellular carcinoma. Clin Microbiol Rev (1992) 1.04
Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-cleavage enzyme, P450scc [corrected], in human steroidogenic tissues. Proc Natl Acad Sci U S A (1987) 1.00
Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas. Proc Natl Acad Sci U S A (2000) 0.99
Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth. Proc Natl Acad Sci U S A (1988) 0.98
Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor. Am J Pathol (1992) 0.98
Genomic imprinting: mechanism and role in human pathology. Am J Pathol (1994) 0.97
Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours. Br J Cancer (1992) 0.97
Detection of type 1 insulinlike growth factor (IGF) receptors in Wilms' tumors. Am J Pathol (1988) 0.97
Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11. Am J Pathol (2001) 0.96
Coordinate developmental regulation of high and low molecular weight mRNAs for rat insulin-like growth factor II. Proc Natl Acad Sci U S A (1986) 0.96
A rodent model for Wilms tumors: embryonal kidney neoplasms induced by N-nitroso-N'-methylurea. Proc Natl Acad Sci U S A (1994) 0.95
The yin and yang of kidney development and Wilms' tumors. Genes Dev (2015) 0.95
Insulin-like growth factor II in the pathogenesis of human neuroblastoma. Am J Pathol (1995) 0.94
Evidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3. Proc Natl Acad Sci U S A (2013) 0.93
Tumour hypoglycaemia: raised tumour IGFII mRNA associated with reduced plasma somatomedins. Br J Cancer (1989) 0.93
Receptor tyrosine kinases as therapeutic targets in rhabdomyosarcoma. Sarcoma (2011) 0.92
Dissociated expression of c-myc and a fos-related competence gene during cardiac myogenesis. Mol Cell Biol (1986) 0.92
Genomic imprinting and cancer. Mol Pathol (1998) 0.91
Isolation of an insulin-like growth factor II cDNA with a unique 5' untranslated region from human placenta. Proc Natl Acad Sci U S A (1988) 0.91
Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways. Am J Pathol (2008) 0.90
The N-myc proto-oncogene and IGF-II growth factor mRNAs are expressed by distinct cells in human fetal kidney and brain. J Cell Biol (1989) 0.89
The cell type-specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome. Am J Pathol (1994) 0.89
Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset. Cell Death Dis (2011) 0.86
Insulin-like growth factor I in cultured rat astrocytes: expression of the gene, and receptor tyrosine kinase. EMBO J (1987) 0.86
Blastemal cells of nephroblastomatosis complex share an onco-developmental antigen with embryonic kidney and Wilms' tumor. An immunohistochemical study on polysialic acid distribution. Am J Pathol (1988) 0.85
Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage Differentiation. Front Endocrinol (Lausanne) (2015) 0.85
Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line. Am J Pathol (1994) 0.83
The IGF signalling pathway in Wilms tumours--a report from the ENCCA Renal Tumours Biology-driven drug development workshop. Oncotarget (2014) 0.82
Morphology and growth characteristics of epithelial cells from classic Wilms' tumors. Am J Pathol (1993) 0.80
Genomic changes in the WT-gene (WT1) in Wilms' tumors and their correlation with histology. Am J Pathol (1992) 0.80
Morphometric analyses of adrenal gland growth in fetal and neonatal sheep. I. The adrenal cortex. J Anat (1989) 0.80
Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients. Eur J Med Res (2011) 0.79
Tumour suppression associated with expression of human insulin-like growth factor II. Br J Cancer (1991) 0.79
Genetic background of adrenocortical tumor development. World J Surg (2001) 0.78
Detection of anti-sense transcripts of the insulin-like growth factor-2 gene in Wilms' tumor. Am J Pathol (1993) 0.78
Identification of a novel transcription unit in the human insulin-like growth factor-II gene. Biochem J (1991) 0.78
Insulin-like growth factors I and II induce cell death in Wilms's tumour cells. Mol Pathol (2001) 0.77
A malignant rhabdoid tumor of the kidney occurring concurrently with a brain tumor: report of a case. Surg Today (2000) 0.77
Normal dosage of the insulin and insulin-like growth factor II genes in patients with the Beckwith-Wiedemann syndrome. Am J Hum Genet (1986) 0.77
Development of targeted therapy for a broad spectrum of solid tumors mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P4 and IGF2-P3 regulatory sequences. Int J Clin Exp Med (2013) 0.76
The role of insulin-like growth factor system in soft tissue sarcomas: from physiopathology to targeted therapeutic approaches. Sarcoma (1998) 0.76
Structural analysis of the human insulin-like growth factor-II P3 promoter. Biochem J (1993) 0.76
Towards an understanding of Wilms' tumour. Int J Exp Pathol (1994) 0.75
Expression of insulin-like growth factor II (IGF)-II) and H19 in murine teratocarcinomas derived from embryonic stem (ES) cells. J Anat (1996) 0.75
Developmental pattern of growth factor production in chick embryo limb buds. J Anat (1989) 0.75
Glutathione S-transferase expression in fetal kidney and Wilms' tumour. Br J Cancer (1990) 0.75
RECK Gene Polymorphism is Associated with Susceptibility and Prognosis of Wilms' Tumor in Chinese Children. Med Sci Monit (2015) 0.75
IGF-II dependent autocrine growth in cell lines derived from renal tumours of childhood. Clin Mol Pathol (1995) 0.75
Introduction to recombinant DNA. J Inherit Metab Dis (1986) 0.75
The sequence of the human genome. Science (2001) 101.55
Models for the specific adhesion of cells to cells. Science (1978) 28.03
Graphic representation of pain. Pain (1976) 14.25
Polymorphic DNA region adjacent to the 5' end of the human insulin gene. Proc Natl Acad Sci U S A (1981) 12.86
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol (1993) 10.87
A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes (1984) 10.09
Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet (1993) 9.34
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33
The highly polymorphic region near the human insulin gene is composed of simple tandemly repeating sequences. Nature (1982) 7.47
Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein. Proc Natl Acad Sci U S A (1988) 7.26
A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell (1987) 7.25
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med (2001) 6.79
Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1) Nature (1996) 6.72
A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet (1996) 6.58
Sequence of the human insulin gene. Nature (1980) 5.76
Cell adhesion. Competition between nonspecific repulsion and specific bonding. Biophys J (1984) 5.72
Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) Nature (1996) 5.32
Ribosomal RNA genes of Saccharomyces cerevisiae. I. Physical map of the repeating unit and location of the regions coding for 5 S, 5.8 S, 18 S, and 25 S ribosomal RNAs. J Biol Chem (1977) 4.76
Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet (1999) 4.48
Relationship between occupations and asbestos-fibre content of the lungs in patients with pleural mesothelioma, lung cancer, and other diseases. Thorax (1977) 4.35
The zootype and the phylotypic stage. Nature (1993) 4.28
Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet (1997) 4.19
Association of genetic variation of the transforming growth factor-alpha gene with cleft lip and palate. Am J Hum Genet (1989) 4.13
A randomized trial of group outpatient visits for chronically ill older HMO members: the Cooperative Health Care Clinic. J Am Geriatr Soc (1997) 4.09
Ribosomal RNA genes of Saccharomyces cerevisiae. II. Physical map and nucleotide sequence of the 5 S ribosomal RNA gene and adjacent intergenic regions. J Biol Chem (1977) 4.03
Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet (1999) 3.95
Choline containing metabolites during cell transfection: an insight into magnetic resonance spectroscopy detectable changes. FEBS Lett (2001) 3.88
Increased endogenous abscisic Acid maintains primary root growth and inhibits shoot growth of maize seedlings at low water potentials. Plant Physiol (1990) 3.85
Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol (1997) 3.83
Nest predation increases with parental activity: separating nest site and parental activity effects. Proc Biol Sci (2000) 3.73
RFLPs for transforming growth factor alpha (TGFA) gene at 2p13. Nucleic Acids Res (1986) 3.72
Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med (2001) 3.55
Analysis of the regions flanking the human insulin gene and sequence of an Alu family member. Nucleic Acids Res (1980) 3.55
The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med (1986) 3.27
Synthesis of hepatitis B surface antigen in mammalian cells: expression of the entire gene and the coding region. J Virol (1983) 3.24
The alpha1 and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett (1996) 3.21
Evidence for a family of human glucose transporter-like proteins. Sequence and gene localization of a protein expressed in fetal skeletal muscle and other tissues. J Biol Chem (1988) 3.18
Yeast SNF1 is functionally related to mammalian AMP-activated protein kinase and regulates acetyl-CoA carboxylase in vivo. J Biol Chem (1994) 3.18
Some observations on the diagnosis of rectal gonorrhoea in both sexes using a selective culture medium. Br J Vener Dis (1966) 3.12
emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis (1999) 3.12
Disease associations. Chance, artifact, or susceptibility genes? Diabetes (1989) 3.12
Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. Nucleic Acids Res (1986) 3.11
Immunostimulant therapy with levamisole for rheumatoid arthritis. Lancet (1976) 3.07
The severe form of alpha thalassaemia is caused by a haemoglobin gene deletion. Nature (1974) 3.04
Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins. Science (1983) 2.97
The LiMB database. Science (1988) 2.89
Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature (1992) 2.86
Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am J Hum Genet (1997) 2.85
Four new anti-inflammatory drugs: responses and variations. Br Med J (1976) 2.84
Treatment of rheumatoid arthritis with fenoprofen: comparison with aspirin. Br Med J (1974) 2.84
Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues. J Biol Chem (1989) 2.81
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet (2008) 2.81
Transcription of hepatitis B virus by RNA polymerase II. Mol Cell Biol (1983) 2.81
Integration of hepatitis B virus sequences and their expression in a human hepatoma cell. Nature (1980) 2.74
Polymorphic human glucose transporter gene (GLUT) is on chromosome 1p31.3----p35. Diabetes (1987) 2.72
Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol (1994) 2.70
Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome. Am J Hum Genet (1992) 2.70
Staging designation for bilateral Wilms' tumours. Med Pediatr Oncol (1991) 2.65
Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci U S A (1988) 2.62
Cell growth and division. IV. Determination of volume growth rate and division probability. Biophys J (1969) 2.57
Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science (1992) 2.50
Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature (1985) 2.49
Vertical or horizontal visual analogue scales. Ann Rheum Dis (1979) 2.49
A homeobox gene, HLXB9, is the major locus for dominantly inherited sacral agenesis. Nat Genet (1998) 2.48
Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature (1983) 2.44
Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med (1996) 2.42
Sequence and functional characterization of a third inositol trisphosphate receptor subtype, IP3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues. J Biol Chem (1993) 2.42
Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor. Nature (1983) 2.41
Cell growth and division. I. A mathematical model with applications to cell volume distributions in mammalian suspension cultures. Biophys J (1967) 2.41
Exon duplication and divergence in the human preproglucagon gene. Nature (1983) 2.37
Fructose transporter in human spermatozoa and small intestine is GLUT5. J Biol Chem (1992) 2.35
Spontaneous remission of multi-system histiocytosis X. Lancet (1984) 2.29
Alternative to current MPH degree program. Health Serv Rep (1972) 2.28
The TACC domain identifies a family of centrosomal proteins that can interact with microtubules. Proc Natl Acad Sci U S A (2000) 2.27
Conotruncal anomaly face syndrome is associated with a deletion within chromosome 22q11. J Med Genet (1993) 2.27
Use of panels of monoclonal antibodies in the differential diagnosis of neuroblastoma and lymphoblastic disorders. Lancet (1983) 2.26
A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet (1994) 2.26
A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr (2001) 2.25
Effect of inhibition of abscisic Acid accumulation on the spatial distribution of elongation in the primary root and mesocotyl of maize at low water potentials. Plant Physiol (1992) 2.25
Autobiographical memory in depression: state or trait marker? Br J Psychiatry (1993) 2.24
Slow virus visna: reproduction in vitro of virus from extrachromosomal DNA. Proc Natl Acad Sci U S A (1984) 2.24
Facilitative glucose transporters: an expanding family. Trends Biochem Sci (1990) 2.22
Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychol Med (2003) 2.16
Prenatal active or passive tobacco smoke exposure and the risk of preterm delivery or low birth weight. Epidemiology (2000) 2.16
Nucleotide sequence of the yeast 5S ribosomal RNA gene and adjacent putative control regions. Nature (1977) 2.15
Sequence of a cDNA clone encoding human preproinsulin-like growth factor II. Nature (1984) 2.13
Induction of transforming growth factor-alpha in activated human alveolar macrophages. Cell (1988) 2.13
Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry (1999) 2.12
Evidence for an association between environmental tobacco smoke exposure and birthweight: a meta-analysis and new data. Paediatr Perinat Epidemiol (1999) 2.11
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol (2008) 2.11
Sleep in patients with remitted bipolar disorders: a meta-analysis of actigraphy studies. Acta Psychiatr Scand (2014) 2.10
Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci U S A (1992) 2.07